Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Journal of Translational Medicine|June 26, 2020
A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinomaZhenyang Liu, Michael Ho-Young Ahn, Tomohiro Kurokawa, et al.The Journal of Clinical Investigation|June 18, 2024
Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant toleranceTakahiro Yokose, Edward S Szuter, Ivy Rosales, et al.Cancer Research Communications|July 29, 2025
Collagen XVII Promotes Pancreatic Ductal Adenocarcinoma Tumor Growth through Regulation of PIK3R5Thomas Hank, Annie Li, Louisa Bolm, et al.Plos One|August 31, 2017
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survivalIlaria Pergolini, Vicente Morales-Oyarvide, Mari Mino-Kenudson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal AdenocarcinomaDavid J Birnbaum, Sebastian K S Begg, Pascal Finetti, et al.Frontiers in Genetics|October 7, 2021
Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic AnalysisHiroki Sato, Takeshi Saito, Hiroshi Horii, et al.Nature Cell Biology|June 27, 2018
Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolismKrushna C Patra, Yasutaka Kato, Yusuke Mizukami, et al.Gut|April 22, 2011
Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypesMari Mino-Kenudson, Carlos Fernández-del Castillo, Yoshifumi Baba, et al.Journal of Gastroenterology|January 12, 2022
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathwayHidemasa Kawabata, Yusuke Ono, Nobue Tamamura, et al.International Journal of Radiation Oncology, Biology, Physics|August 3, 2021
Screening and Validation of Molecular Targeted RadiosensitizersHenning Willers, Xiao Pan, Nathalie Borgeaud, et al.Pageof 6